Advertisement
© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.
Alpharma Inc. announces the U.S. Food and Drug Administration has approved the combination use of bacitracin methylene disalicylate (BMD) and chlortetracycline (Aureomycin) in feed rations to control porcine proliferative enteropathy, or ileitis.
Alpharma Inc. announces the U.S. Food and Drug Administration has approvedthe combination use of bacitracin methylene disalicylate (BMD®) andchlortetracycline (Aureomycin®) in feed rations to control porcine proliferativeenteropathy, or ileitis. According to the National Animal Health MonitoringSystem, 96 percent of operations may be affected by ileitis in the UnitedStates. In addition, pneumonia and ileitis combined to account for morethan 52 percent of growth finish death losses resulting in millions of dollarsin economic loss.
Producers no longer have to choose which disease to control, the companysays. They now have the ability to treat respiratory disease and controlileitis with a single program with BMD plus Aureomycin, the company says.
For fastest response call (201) 947-7774 or visit the Web site at
